论文部分内容阅读
目的分析布地奈德联合盐酸氨溴索雾化吸入治疗小儿支气管肺炎的疗效。方法选取我院2013年5月~2014年8月收治的支原体肺炎患儿166例作为研究对象,根据患儿的治疗方式将其分为联合用药组与单独用药组,各83例,单独用药组患儿仅给予盐酸氨溴索雾化吸入治疗,联合用药组采用布地奈德联合盐酸氨溴索雾化吸入治疗,观察患儿的治疗总有效率、72 h退热率、不良反应发生率。结果联合用药组患儿的治疗总有效率、72 h退热率明显高于对照组,差异有统计学意义(P<0.05),两组患儿不良反应发生率比较,差异无统计学意义(P>0.05)。结论布地奈德联合盐酸氨溴索雾化吸入治疗小儿支气管肺炎具有良好的疗效。
Objective To analyze the curative effect of budesonide combined with ambroxol hydrochloride inhalation on bronchial pneumonia in children. Methods A total of 166 children with mycoplasmal pneumonia admitted from May 2013 to August 2014 in our hospital were selected as the study objects. According to the treatment of children, the patients were divided into the combination group and the single drug group, 83 cases in each group. Children were given inhalation of ambroxol hydrochloride inhalation only. Combination therapy with budesonide and ambroxol hydrochloride inhalation was used to treat children. The total effective rate of treatment, the rate of 72-hour fever and the incidence of adverse reactions were observed. Results The total effective rate of treatment in children in combination group was significantly higher than that in control group at 72 h (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups P> 0.05). Conclusion Budesonide combined with ambroxol hydrochloride inhalation in children with bronchopneumonia has a good effect.